当前位置: 首页 > 详情页

Cells susceptible to epithelial- mesenchymal transition are enriched in stem- like side population cells from prostate cancer

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [1]Capital Med Univ, Beijing Anzhen Hosp, Dept Urol, Beijing 100029, Peoples R China; [2]Beijing Shijingshan Hosp, Dept Urol, Beijing 100043, Peoples R China; [3]Peking Univ, Dept Endocrinol, Beijing Jishuitan Hosp, Clin Med Coll 4, Beijing 100035, Peoples R China; [4]Capital Med Univ, Beijing Anzhen Hosp, Dept Urol, Anzhenli St, Beijing 100029, Peoples R China
出处:
ISSN:

关键词: side population cells cancer stem cells epithelial-mesenchymal transition prostate cancer hypoxia inducible factor-1 heterogeneity

摘要:
Accumulating evidence suggests that epithelial-mesenchymal transition (EMT) acts as an important factor for the promotion of tumor progression. Strategies for suppressing EMT remain the subject of ongoing research. In the present study, fluorescence-activated cell sorting (FACS) was used to isolate side population (SP) cells from human prostate cancer (PCa) cell lines and xenograft tissues. After identifying their molecular and functional stem-like characteristics, stem-like SP cells from a cell line and from xenograft tissue were transfected with hypoxia inducible factor-1 (HIF-1). The potential of the prostate stem-like SP cells to undergo EMT was compared with that in their bulk counterparts after HIF-1 introduction. Stem-like SP cells acquired more complete EMT molecular features and exhibited stronger aggressive capability than the homologous bulk population cells both in vitro (proliferation and invasion) and in vivo (tumorigenesis and metastasis formation). We, therefore, concluded that EMT is closely associated with tumor heterogeneity, and that PCa cells susceptible to EMT are enriched in stem-like SP cells. These findings disclose a new approach, targeting the cellular basis of the EMT process that may help to identify effective and accurate methods for suppressing tumor growth and preventing distant dissemination.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2013]版:
大类 | 4 区 医学
小类 | 4 区 肿瘤学
最新[2023]版:
大类 | 3 区 医学
小类 | 4 区 肿瘤学
JCR分区:
出版当年[2012]版:
Q3 ONCOLOGY
最新[2023]版:
Q2 ONCOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2012版] 出版当年五年平均 出版前一年[2011版] 出版后一年[2013版]

第一作者:
第一作者机构: [1]Capital Med Univ, Beijing Anzhen Hosp, Dept Urol, Beijing 100029, Peoples R China;
通讯作者:
通讯机构: [1]Capital Med Univ, Beijing Anzhen Hosp, Dept Urol, Beijing 100029, Peoples R China; [4]Capital Med Univ, Beijing Anzhen Hosp, Dept Urol, Anzhenli St, Beijing 100029, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16461 今日访问量:0 总访问量:871 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院